Cresco Labs Reports $215 Million Net Loss For 2022
Cresco Labs (CSE: CL) saw its revenues in 2022 increase 3% over the prior year. The firm this morning reported
Read more
Cresco Labs
P Diddy To Spend $185 Million Acquiring Cannabis Assets From Cresco Labs, Columbia Care
Cresco Labs (CSE: CL) appears to be monetizing the appointment of director Tarik Brooks, which occurred last year. Brooks is
Read more
Cresco Labs: Canaccord Cuts Price Target On Muted Growth, Pricing Challenges
On August 17, Cresco Labs (CSE: CL) reported its second quarter financial results. The company announced revenues grew by $218
Read more
Cresco Labs Posts 1.8% Sequential Revenue Growth In Second Quarter
Cresco Labs (CSE: CL) was the latest cannabis operator to report earnings this morning for the second quarter. Growth has
Read more
US Cannabis: Stifel Expects “Limited To No Sales Growth”
Earlier this month, Stifel-GMP came out with their US cannabis second quarter preview, calling the bottom on the drawdown but
Read more
Cresco Labs Receives Court Approval To Proceed With Columbia Care Acquisition
Cresco Labs (CSE: CL) is inching closer to finalizing its previously announced acquisition of Columbia Care (CSE: CCHW). The two
Read more
Canaccord Lowers Cresco Labs’ Price Target To $9.50
On May 18th, Cresco Labs (CSE: CL) reported its first quarter financial results. The company reported revenues of $214 million,
Read more
Cresco Labs Posts $214.4 Million In Revenue, $23.7 Million Net Loss In Q1 2022
Cresco Labs (CSE: CL) released its Q1 2022 financials, highlighting a quarterly revenue of $214.4 million. This is a decrease from
Read more
Haywood Cuts Cresco Labs Price Target To $15.50 On Poor Earnings
At the tail end of March, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many investors as the
Read more
Cresco Labs: Stifel Slashes Price Target From $30 To $8 Following Poor Q4 Results
On March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many investors as the company put
Read more